Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus

N. G. Docherty; C. W. le Roux Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus Nature reviews nephrology
Chronic Kidney Disease

Weight loss interventions and progression of diabetic kidney disease

N. G. Docherty; A. L. Canney; C. W. le Roux Weight loss interventions and progression of diabetic kidney disease Curr Diab Rep
Chronic Kidney Disease

Obesity diabetes and the role of bile acids in metabolism

G. H. Tomkin; D. Owens Obesity diabetes and the role of bile acids in metabolism J Transl Int Med
Insulin Resistance & Diabetes

Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes

O. O. Ojo; D. K. Srinivasan; B. O. Owolabi; P. R. Flatt; Y. H. A. Abdel-Wahab Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes Biochimie
Appetite & Satiety Insulin Resistance & Diabetes

Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation

A. M. Murphy; A. Thomas; S. J. Crinion; B. D. Kent; M. M. Tambuwala; A. Fabre; J. L. Pepin; H. M. Roche; C. Arnaud; S. Ryan Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Eur Respir J
Insulin Resistance & Diabetes

Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome

W. Newmarch; M. Weiler; B. Casserly Obesity cardiomyopathy: the role of obstructive sleep apnea and obesity hypoventilation syndrome Ir J Med Sci

Risk of iron overload in obesity and implications in metabolic health

A. Moore Heslin; A. O’donnell; M. Buffini; A. P. Nugent; J. Walton; A. Flynn; B. A. McNulty Risk of iron overload in obesity and implications in metabolic health Nutrients

Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies

M. A. McArdle; O. M. Finucane; R. M. Connaughton; A. M. McMorrow; H. M. Roche Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies Front Endocrinol (Lausanne)

Emerging therapeutic potential for peptide YY for obesity-diabetes

R. A. Lafferty; P. R. Flatt; N. Irwin Emerging therapeutic potential for peptide YY for obesity-diabetes Peptides
Insulin Resistance & Diabetes

Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes

R. A. Lafferty; P. R. Flatt; N. Irwin Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes Curr Opin Endocrinol Diabetes Obes
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page7 Page8 Page9 … Page53 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI